246 related articles for article (PubMed ID: 29743597)
1. MASTL overexpression promotes chromosome instability and metastasis in breast cancer.
Rogers S; McCloy RA; Parker BL; Gallego-Ortega D; Law AMK; Chin VT; Conway JRW; Fey D; Millar EKA; O'Toole S; Deng N; Swarbrick A; Chastain PD; Cesare AJ; Timpson P; Caldon CE; Croucher DR; James DE; Watkins DN; Burgess A
Oncogene; 2018 Aug; 37(33):4518-4533. PubMed ID: 29743597
[TBL] [Abstract][Full Text] [Related]
2. MASTL: A novel therapeutic target for Cancer Malignancy.
Fatima I; Singh AB; Dhawan P
Cancer Med; 2020 Sep; 9(17):6322-6329. PubMed ID: 32692487
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic relevance of the PP2A-B55 inhibitory kinase MASTL/Greatwall in breast cancer.
Álvarez-Fernández M; Sanz-Flores M; Sanz-Castillo B; Salazar-Roa M; Partida D; Zapatero-Solana E; Ali HR; Manchado E; Lowe S; VanArsdale T; Shields D; Caldas C; Quintela-Fandino M; Malumbres M
Cell Death Differ; 2018 May; 25(5):828-840. PubMed ID: 29229993
[TBL] [Abstract][Full Text] [Related]
4. MASTL inhibition promotes mitotic catastrophe through PP2A activation to inhibit cancer growth and radioresistance in breast cancer cells.
Yoon YN; Choe MH; Jung KY; Hwang SG; Oh JS; Kim JS
BMC Cancer; 2018 Jul; 18(1):716. PubMed ID: 29976159
[TBL] [Abstract][Full Text] [Related]
5. E2F8 confers cisplatin resistance to ER+ breast cancer cells via transcriptionally activating MASTL.
Tian J; Lin Y; Yu J
Biomed Pharmacother; 2017 Aug; 92():919-926. PubMed ID: 28605876
[TBL] [Abstract][Full Text] [Related]
6. The Greatwall kinase safeguards the genome integrity by affecting the kinome activity in mitosis.
Bisteau X; Lee J; Srinivas V; Lee JHS; Niska-Blakie J; Tan G; Yap SYX; Hom KW; Wong CK; Chae J; Wang LC; Kim J; Rancati G; Sobota RM; Tan CSH; Kaldis P
Oncogene; 2020 Oct; 39(44):6816-6840. PubMed ID: 32978522
[TBL] [Abstract][Full Text] [Related]
7. Loss of the Greatwall Kinase Weakens the Spindle Assembly Checkpoint.
Diril MK; Bisteau X; Kitagawa M; Caldez MJ; Wee S; Gunaratne J; Lee SH; Kaldis P
PLoS Genet; 2016 Sep; 12(9):e1006310. PubMed ID: 27631493
[TBL] [Abstract][Full Text] [Related]
8. MASTL is the human orthologue of Greatwall kinase that facilitates mitotic entry, anaphase and cytokinesis.
Voets E; Wolthuis RM
Cell Cycle; 2010 Sep; 9(17):3591-601. PubMed ID: 20818157
[TBL] [Abstract][Full Text] [Related]
9. MASTL(Greatwall) regulates DNA damage responses by coordinating mitotic entry after checkpoint recovery and APC/C activation.
Wong PY; Ma HT; Lee HJ; Poon RY
Sci Rep; 2016 Feb; 6():22230. PubMed ID: 26923777
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of Microtubule Associated Serine/threonine Kinase Like Expression Inhibits Gastric Cancer Cell Growth and Induces Apoptosis by Activation of ERK1/2 and Inactivation of NF-κB Signaling.
An CX; Xie SP; Li HL; Hu YH; Niu R; Zhang LJ; Jiang Y; Li Q; Zhou YN
Curr Med Sci; 2021 Feb; 41(1):108-117. PubMed ID: 33582914
[TBL] [Abstract][Full Text] [Related]
11. MASTL promotes cell contractility and motility through kinase-independent signaling.
Taskinen ME; Närvä E; Conway JRW; Hinojosa LS; Lilla S; Mai A; De Franceschi N; Elo LL; Grosse R; Zanivan S; Norman JC; Ivaska J
J Cell Biol; 2020 Jun; 219(6):. PubMed ID: 32311005
[TBL] [Abstract][Full Text] [Related]
12. The MASTL/PP2A cell cycle kinase-phosphatase module restrains PI3K-Akt activity in an mTORC1-dependent manner.
Sanz-Castillo B; Hurtado B; Vara-Ciruelos D; El Bakkali A; Hermida D; Salvador-Barbero B; Martínez-Alonso D; González-Martínez J; Santiveri C; Campos-Olivas R; Ximénez-Embún P; Muñoz J; Álvarez-Fernández M; Malumbres M
EMBO J; 2023 Jan; 42(2):e110833. PubMed ID: 36354735
[TBL] [Abstract][Full Text] [Related]
13. The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells.
Li JP; Yang YX; Liu QL; Pan ST; He ZX; Zhang X; Yang T; Chen XW; Wang D; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1627-52. PubMed ID: 25834401
[TBL] [Abstract][Full Text] [Related]
14. FYN promotes breast cancer progression through epithelial-mesenchymal transition.
Xie YG; Yu Y; Hou LK; Wang X; Zhang B; Cao XC
Oncol Rep; 2016 Aug; 36(2):1000-6. PubMed ID: 27349276
[TBL] [Abstract][Full Text] [Related]
15. Thrombocytopenia-associated mutations in Ser/Thr kinase MASTL deregulate actin cytoskeletal dynamics in platelets.
Hurtado B; Trakala M; Ximénez-Embún P; El Bakkali A; Partida D; Sanz-Castillo B; Álvarez-Fernández M; Maroto M; Sánchez-Martínez R; Martínez L; Muñoz J; García de Frutos P; Malumbres M
J Clin Invest; 2018 Dec; 128(12):5351-5367. PubMed ID: 30252678
[TBL] [Abstract][Full Text] [Related]
16. AKT Regulates Mitotic Progression of Mammalian Cells by Phosphorylating MASTL, Leading to Protein Phosphatase 2A Inactivation.
Reshi I; Nisa MU; Farooq U; Gillani SQ; Bhat SA; Sarwar Z; Nabi N; Fazili KM; Andrabi S
Mol Cell Biol; 2020 Apr; 40(10):. PubMed ID: 32123010
[TBL] [Abstract][Full Text] [Related]
17. The Oncogenic Functions of MASTL Kinase.
Marzec K; Burgess A
Front Cell Dev Biol; 2018; 6():162. PubMed ID: 30555827
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of BAG‑1 in T47D cells promotes resistance to tamoxifen via activation of the PI3K/Akt/mTOR signaling pathway.
Lu S; Du Y; Cui F; Feng X; Ma Y; Liu H
Oncol Rep; 2019 Mar; 41(3):1901-1910. PubMed ID: 30747221
[TBL] [Abstract][Full Text] [Related]
19. PIK3R1 targeting by miR-21 suppresses tumor cell migration and invasion by reducing PI3K/AKT signaling and reversing EMT, and predicts clinical outcome of breast cancer.
Yan LX; Liu YH; Xiang JW; Wu QN; Xu LB; Luo XL; Zhu XL; Liu C; Xu FP; Luo DL; Mei P; Xu J; Zhang KP; Chen J
Int J Oncol; 2016 Feb; 48(2):471-84. PubMed ID: 26676464
[TBL] [Abstract][Full Text] [Related]
20. Mastl kinase, a promising therapeutic target, promotes cancer recurrence.
Wang L; Luong VQ; Giannini PJ; Peng A
Oncotarget; 2014 Nov; 5(22):11479-89. PubMed ID: 25373736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]